VisualDx, a medical informatics company, is celebrating the one-year anniversary of its brainchild Project IMPACT, a global collaborative of nine organizations aiming to reduce health disparities and ...

VisualDx, a health technology company that developed a mobile-based skin cancer assessment tool for clinical decision support and a patient facing website, has teamed up with Science 37 to provide ...

ROCHESTER, N.Y.--(BUSINESS WIRE)--Rochester-based VisualDx, has enhanced its VisualDx app with Core ML, a new framework enabling on-device machine learning to create powerful, rich experiences. The ...

VisualDx is a clinical decision support system used by more than 2,300 hospitals, clinics, and medical schools around the world VisualDx's system seeks to enhance identification of people who may have ...

VisualDx, a Rochester, New York-based company that designed a clinical decision support tool for doctors, has expanded its innovative thinking to the world of consumers. At the Health 2.0 conference ...

ROCHESTER, N.Y.--(BUSINESS WIRE)--VisualDx, a global leader in web-based clinical decision support (CDS), today announced that it has entered into an agreement with Janssen Biotech, Inc., one of the ...

Absolut Skin, a dermatology-led skincare and health-technology platform, has announced its partnership with VisualDx, to bring artificial intelligence (AI) powered skin condition identification and ...

The astronauts currently on the International Space Station rely on telemedicine for everything from coughs to bruises. But as Dr. Shannan Moynihan, deputy chief of space and occupational medicine at ...

VisualDx will debut a new version of its clinical decision support system at HIMSS16. The company is growing its image- and graphics-oriented software from supporting skin, eye and oral care ...

AI, machine-learning technology & more: VisualDx CEO Dr. Art Papier shares insights on future innovation of clinical informatics Art Papier, MD, CEO of diagnostic clinical decision support system ...

FLORENCE, Italy and NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.